Evaluation of CRISPR/Cas9 exon‐skipping vector for choroideremia using human induced pluripotent stem cell‐derived RPE-Reference-Cited by-同舟云学术

Evaluation of CRISPR/Cas9 exon‐skipping vector for choroideremia using human induced pluripotent stem cell‐derived RPE

Author:

Iwagawa Toshiro¹²,Masumoto Hiroki³⁴,Tabuchi Hitoshi⁴⁵,Tani Kenzaburo⁶^ORCID,Conklin Bruce R.⁷⁸,Watanabe Sumiko¹²

Affiliation:

1. Division of Molecular and Developmental Biology, Institute of Medical Science University of Tokyo Tokyo Japan

2. Department of Retinal Biology and Pathology University of Tokyo Hospital, University of Tokyo Tokyo Japan

3. Xeno Hoc, Inc. Tokyo Japan

4. Department of Ophthalmology Tsukazaki Hospital Himeji Hyogo Japan

5. Department of Technology and Design Thinking for Medicine Hiroshima University Hiroshima Japan

6. Laboratory of ALA Advanced Medical Research, Institute for quantitative Biosciences University of Tokyo Tokyo Japan

7. Gladstone Institutes San Francisco CA USA

8. Departments of Medicine, Ophthalmology and Cellular and Molecular Pharmacology University of California San Francisco CA USA

Funder

Japan Society for the Promotion of Science

National Institutes of Health

Publisher

Wiley

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Link

Reference41 articles.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献